We conducted a prospective, randomized study to clarify the role of radiotherapy of the primary tumor in limited small-cell cancer of the lung. After stratification for sex and for performance score based on the ability to ambulate, patients were randomly assigned to receive initial radiotherapy plus chemotherapy, delayed radiotherapy plus chemotherapy, or chemotherapy alone. The chemotherapy consisted of cyclophosphamide, etoposide (VP-16-213), and vincristine, with doxorubicin subsequently replacing etoposide in alternate cycles 7 through 18. Chemotherapy was given every three weeks for 18 months. The radiotherapy comprised 4000 rad in four weeks, followed by a 1000-rad "boost" directed against residual disease. All patients received prophylactic whole-brain radiation. The patients enrolled totaled 426, and 399 were evaluable. There was a statistically significant difference in the frequency of complete responses in favor of the two radiotherapy regimens (P = 0.0013). Failure-free survival was also longer with these two regimens (P less than 0.001), as was the interval before treatment failure in the chest (P less than 0.001) and overall survival (P = 0.0099). As expected, toxic effects--chiefly neutropenia--were also increased. The addition of radiotherapy of the primary tumor to combination chemotherapy improved both complete-response rates and survival, with increased but acceptable toxicity.
This article has been cited by other articles:
Demedts, I. K., Vermaelen, K. Y., van Meerbeeck, J. P.
(2010). Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J
35: 202-215
[Abstract][Full Text]
Socinski, M. A., Bogart, J. A.
(2007). Limited-Stage Small-Cell Lung Cancer: The Current Status of Combined-Modality Therapy. JCO
25: 4137-4145
[Abstract][Full Text]
Samson, D. J., Seidenfeld, J., Simon, G. R., Turrisi, A. T. III, Bonnell, C., Ziegler, K. M., Aronson, N.
(2007). Evidence for Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest
132: 314S-323S
[Abstract][Full Text]
Lally, B. E., Urbanic, J. J., Blackstock, A. W., Miller, A. A., Perry, M. C.
(2007). Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?. The Oncologist
12: 1096-1104
[Abstract][Full Text]
Socinski, M. A., Weissman, C., Hart, L. L., Beck, J. T., Choksi, J. K., Hanson, J. P., Prager, D., Monberg, M. J., Ye, Z., Obasaju, C. K.
(2006). Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer. JCO
24: 4840-4847
[Abstract][Full Text]
Spiro, S. G., James, L. E., Rudd, R. M., Trask, C. W., Tobias, J. S., Snee, M., Gilligan, D., Murray, P. A., de Elvira, M. C. R., O'Donnell, K. M., Gower, N. H., Harper, P. G., Hackshaw, A. K.
(2006). Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis. JCO
24: 3823-3830
[Abstract][Full Text]
Vokes, E. E., Perry, M. C., Kindler, H. L., Green, M. R.
(2006). The cancer and leukemia group B respiratory committee.. Clin. Cancer Res.
12: 3581s-3588s
[Abstract][Full Text]
Bogart, J. A., Seagren, S. L., Glicksman, A.
(2006). Radiation oncology research in the cancer and leukemia group B.. Clin. Cancer Res.
12: 3628s-3634s
[Abstract][Full Text]
De Ruysscher, D., Pijls-Johannesma, M., Bentzen, S. M., Minken, A., Wanders, R., Lutgens, L., Hochstenbag, M., Boersma, L., Wouters, B., Lammering, G., Vansteenkiste, J., Lambin, P.
(2006). Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer. JCO
24: 1057-1063
[Abstract][Full Text]
Myers, J. N., O'Neil, K. M., Walsh, T. E., Hoffmeister, K. J., Venzon, D. J., Johnson, B. E.
(2005). The Pulmonary Status of Patients With Limited-Stage Small Cell Lung Cancer 15 Years After Treatment With Chemotherapy and Chest Irradiation. Chest
128: 3261-3268
[Abstract][Full Text]
Ettinger, D. S., Berkey, B. A., Abrams, R. A., Fontanesi, J., Machtay, M., Duncan, P. J., Curran, W. J. Jr, Movsas, B., Byhardt, R. W.
(2005). Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study. JCO
23: 4991-4998
[Abstract][Full Text]
Fried, D. B., Morris, D. E., Poole, C., Rosenman, J. G., Halle, J. S., Detterbeck, F. C., Hensing, T. A., Socinski, M. A.
(2004). Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer. JCO
22: 4837-4845
[Abstract][Full Text]
Huncharek, M., McGarry, R.
(2004). A Meta-Analysis of the Timing of Chest Irradiation in the Combined Modality Treatment of Limited-Stage Small Cell Lung Cancer. The Oncologist
9: 665-672
[Abstract][Full Text]
Brenner, B., Tang, L. H., Klimstra, D. S., Kelsen, D. P.
(2004). Small-Cell Carcinomas of the Gastrointestinal Tract: A Review. JCO
22: 2730-2739
[Abstract][Full Text]
Lee, S.-H., Ahn, Y. C., Kim, H. J., Lim, D. H., Lee, S. I., Nam, E., Park, S. H., Park, J., Lee, K.-E., Park, J. O., Kim, K., Kim, W. S., Jung, C. W., Im, Y.-H., Kang, W. K., Lee, M. H., Park, K.
(2003). Early Concurrent Chemoradiotherapy with Prolonged Oral Etoposide and Cisplatin for Limited-stage Small-cell Lung Cancer. Jpn J Clin Oncol
33: 620-625
[Abstract][Full Text]
Reck, M., von Pawel, J., Macha, H.-N., Kaukel, E., Deppermann, K.-M., Bonnet, R., Ulm, K., Hessler, S., Gatzemeier, U.
(2003). Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer. JNCI J Natl Cancer Inst
95: 1118-1127
[Abstract][Full Text]
Booton, R, Jones, M, Thatcher, N
(2003). Lung cancer * 7: Management of lung cancer in elderly patients. Thorax
58: 711-720
[Full Text]
Huang, J., Barbera, L., Brouwers, M., Browman, G., Mackillop, W. J.
(2003). Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review. JCO
21: 555-563
[Abstract][Full Text]
Machtay, M.
(2002). The Early Rad Catches the Tumor?. JCO
20: 3045-3047
[Full Text]
Takada, M., Fukuoka, M., Kawahara, M., Sugiura, T., Yokoyama, A., Yokota, S., Nishiwaki, Y., Watanabe, K., Noda, K., Tamura, T., Fukuda, H., Saijo, N.
(2002). Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104. JCO
20: 3054-3060
[Abstract][Full Text]
Khurshid, I, Anderson, L C
(2002). Non-infectious pulmonary complications after bone marrow transplantation. Postgrad. Med. J.
78: 257-262
[Abstract][Full Text]
Komaki, R., Chasen, M. H., Travis, W. D., Putnam, J. B., Fossella, F. V., Byhardt, R. W., Ro, J. Y.
(2001). Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis. RadioGraphics
21: 1573-1596
[Full Text]
Cohen, M. H.
(2000). Thalidomide in the treatment of high-grade gliomas.. JCO
18: 3453-3453
[Full Text]
Han, J.-Y., Kim, K. W., Kim, J. A., Kang, J. H., Jin, J.-Y., Hong, Y. S., Park, S. Y., Song, J.-S., Park, J. W., Kim, H.-K., Lee, K. S., Choi, B. G.
(2000). A Phase II Study of a Daily 4 Schedule of Vinorelbine Plus Cisplatin for Advanced Non-small Cell Lung Cancer. Jpn J Clin Oncol
30: 435-439
[Abstract][Full Text]
Hugli, A., Moro, D., Mermillod, B., Bolla, M., Alberto, P., Bonnefoi, H., Miralbell, R.
(2000). Phase II Trial of Up-Front Accelerated Thoracic Radiotherapy Combined With Chemotherapy and Optional Up-Front Prophylactic Cranial Irradiation in Limited Small-Cell Lung Cancer. JCO
18: 1662-1667
[Abstract][Full Text]
Levitan, N., Dowlati, A., Shina, D., Craffey, M., Mackay, W., DeVore, R., Jett, J., Remick, S. C., Chang, A., Johnson, D.
(2000). Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma. JCO
18: 1102-1102
[Abstract][Full Text]
Johnson, D. H.
(1999). Management of Small Cell Lung Cancer* : Current State of the Art. Chest
116
: 525S-530S
[Abstract][Full Text]
Elias, A.
(1999). Hematopoietic Stem Cell Transplantation for Small Cell Lung Cancer*. Chest
116
: 531S-538S
[Abstract][Full Text]
Marks, L. B., Sibley, G.
(1999). The Rationale and Use of Three-Dimensional Radiation Treatment Planning for Lung Cancer*. Chest
116
: 539S-545S
[Abstract][Full Text]
Bonner, J. A., Sloan, J. A., Shanahan, T. G., Brooks, B. J., Marks, R. S., Krook, J. E., Gerstner, J. B., Maksymiuk, A., Levitt, R., Mailliard, J. A., Tazelaar, H. D., Hillman, S., Jett, J. R.
(1999). Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma. JCO
17: 2681-2681
[Abstract][Full Text]
Elias, A., Ibrahim, J., Skarin, A. T., Wheeler, C., McCauley, M., Ayash, L., Richardson, P., Schnipper, L., Antman, K. H., Frei, E. III
(1999). Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome. JCO
17: 1175-1175
[Abstract][Full Text]
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., Johnson, D. H.
(1999). Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide. NEJM
340: 265-271
[Abstract][Full Text]
Lichter, A. S., Lawrence, T. S.
(1995). Recent Advances in Radiation Oncology. NEJM
332: 371-379
[Full Text]
Richardson, G. E., Venzon, D. J., Phelps, R., Edison, M., Brown, M., Frame, J. N., Ihde, D. C., Johnson, B. E.
(1993). Application of an Algorithm for Staging Small-cell Lung Cancer Can Save One Third of the Initial Evaluation Costs. Arch Intern Med
153: 329-337
[Abstract]
Lin, A. Y., Ihde, D. C.
(1992). Recent Developments in the Treatment of Lung Cancer. JAMA
267: 1661-1664
[Abstract]
Previous
